Locations:
Search IconSearch

Concurrent Robotic Partial Nephrectomy and Pyelolithotomy (Video)

Tips and tricks offered in this multipart surgery

By Jihad Kaouk, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Despite the fact that the incidence of urolithiasis and renal neoplasm are rising, encountering both entities in a single kidney is noteworthy. This narrated operative video outlines primary surgical steps in the concurrent management of a renal calculus and an ipsilateral renal neoplasm using a robotic platform.

Method

A 53-year-old male was diagnosed with a 1.7 cm left renal pelvis calculus and a 4.7 cm enhancing ipsilateral upper pole renal mass (R.E.N.A.L nephrometry score 2+1+3+a+2=8a) after an episode of acute left flank pain. After reviewing preoperative imaging, we planned a single setting approach using a robotic platform.

Primary steps in the procedure were:

  1. Hilum dissection.
  2. Kidney defatting and mobilization.
  3. Ureter dissection up to the renal pelvis.
  4. Intraoperative ultrasound for tumor demarcation and stone localization.
  5. Anterior pyelolithotomy using two robotic arms.
  6. Endoscopic pyeloscopy and stone extraction.
  7. Double J stent placement and pyelotomy closure.
  8. Excision of renal mass.
  9. Renorraphy.

Results

Operative time was 180 minutes and estimated blood loss was 100 ml; warm ischemia time was 17 minutes. There were no intra- or postoperative complications. The patient was discharged home in postoperative day three. Final pathology reported a 3.4 cm mass consistent with a clear cell renal cell carcinoma, with a TNM staging pT1aNx and negative surgical margin. The double J stent was removed after four weeks and the patient remained asymptomatic at one month postoperatively.

Conclusion

Robotic partial nephrectomy and pyelolithotomy is effective for concurrent renal stone and a kidney mass using the same surgical access. The minimally invasive approach will diminish the need for more than one surgery, preserve renal function and maintain oncological outcomes. This option should be contemplated when managing patients with both kidney stone and cancer in an ipsilateral kidney.

Advertisement

This video was produced with the help of Clinical Fellow Juan Garisto, MD, and Urology Resident Hans Arora, MD, PhD.

Advertisement

Related Articles

Dr. Lundy counseling a patient in clinic
November 25, 2025/Urology & Nephrology
Clinical Pearls for Treating Infertility and Low Testosterone in Men

Reproductive urologists publish a contemporary review to guide practice

Dr. Hoang Roberts in the operating room
November 20, 2025/Urology & Nephrology/Urology
Utilizing the Single-Port Robot for Sacrocolpopexy and Hysterectomy To Empower Patients

Two recent cases show favorable pain and cosmesis outcomes

Person shaking pills into their hands
September 26, 2025/Urology & Nephrology/Nephrology
IgA Nephropathy: Reviewing the Evidence on Current and Future Therapies

Proteinuria reduction remains the most important treatment target.

Pathology slide of IgA
September 25, 2025/Urology & Nephrology/Nephrology
IgA Nephropathy: Reviewing the Evidence on Pathogenesis, Diagnosis and Prognosis

IgA nephropathy is a relatively common autoimmune glomerular disease that can be diagnosed only by biopsy

Dr. Almassi in the operating room
Nerve-Sparing Cystectomy Preserves Sexual Function in Men With Bladder Cancer

Oncologic and functional outcomes are promising, but selection is key

Urodynamics device in blue glove
June 13, 2025/Urology & Nephrology
Novel Urodynamic System Receives FDA Clearance

Cleveland Clinic is first to use the device, known formerly as the UroMonitor

Dr. Eltemamy in the operating room
Nutcracker Syndrome: A Rare Diagnosis and Innovative Robotic Surgery

First single-port renal vein transposition reduces recovery time and improves outcomes

Ad